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The use of thiocyanate as an anti-sickling drug is currently on the increase among sickle cell disease 
(SCD) patients. The continuous use of this substance without sufficient toxicity data does not 
guaranty continuously functional and healthy internal organs among the SCD patients that are 
susceptible to multi-organ failure such as hepatic failure. Hence this study was performed to 
elucidate the consequence(s)of thiocyanate administration on the liver of adult male wistar rats. 
Twenty adult male wistar rats with an average weight of 234.5g were used. The rats were grouped 
into four (A, B, C & D) with five animals in each group. Group A represented the control and was 
given only 1ml of distilled water daily while B,C,&D received 1ml of thiocyanate solution at doses of 
10mg/Kg/day, 20mg/Kg/day, & 30mg/Kg/day for twenty-eight (28) days. The administration was 
carefully done with the use of an oral cannula. Thereafter, the rats were sacrificed via cervical 
dislocation. The rats were dissected and blood samples were immediately collected from the apex of 
the heart for the analysis of serum total bilirubin. A fraction of the liver was cut to prepare 
homogenates for biochemical enzymes (alanine aminotransferase-ALT, aspartate aminotransferase-
AST) analysis. Thereafter the animals were wholly perfused with normal saline and then fixed with 
4% paraformaldehyde. The fixed liver tissues were then taken for histological assessments. The 
slide sections (H&E and PAS stains) in the treated groups showed varying degrees (mild to severe 
disruption of hepatocellular morphology plus prominence and widening of sinusoids) of thiocyanate-
induced liver damage. But hepatocellular appearance was normal in the control group. Biochemical 
assays of serum total bilirubin and tissue AST increased fairly with increasing dose although this 
was not significant. The increase in tissue level of ALT in group B was also not significant with 
respect to the control. But increase in ALT level was found to be significant in groups C&D when 
compared with the control. Therefore, this study can be used to infer that SCN use in sickle cell 
disease management regimen can cause hepatocellular damage in wistar rats. 
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INTRODUCTION 
Thiocyanates (SCN) are a group of 
compounds formed from the combination of 
sulphur, carbon, and nitrogen. Thiocyanates 
are found in various foods and plants; they 
are produced basically from the reaction of 
free cyanide with sulphur. This reaction takes 
place within the environment (e.g. in 
industrial waste streams that contain cyanide) 
and in the human body after cyanide is 
swallowed or absorbed (ATSDR, 2006). 
Thiocyanate is the major product formed from 
cyanide that passes into the body as the body 
attempts to get rid itself of cyanide. Albeit 
thiocyanates are less harmful than cyanide in 
humans, they are known to affect the thyroid 
glands, reducing the ability of the gland to 
produce hormones that are necessary for the 
normal function of the body (ATSDR, 2006). 
Thiocyanate inhibits formation of (the 
abnormally shaped) sickle cells that contribute 
to obstruction of blood vessels. The 
concurrent intake of thiocyanate, 
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eicosapentaenoic acid (EPA), and 
docosahexaenoic acid (DHA) can offer 
synergistic clinical benefit in sickle cell disease 
(SCD) than each agent taken singly (Okpala 
et al., 2013).Thiocyanate has long been used 
to resolve cases of sickle cell crisis in-vitro and 
few preliminary clinical trials with a 
disappearance of pain and discomfort in the 
patients (Oyewole and Malomo, 2008). 
However, it has since been neglected only to 
be rediscovered many decades later (Oji, 
1986). Thiocyanate in red blood cells is 
oxidised into cyanate by the haemoglobin 
which acts as a peroxidase (Chung and Wood, 
1971). 
 The liver is one of the prime organs in the 
body that performs several different functions 
in the body. Although the liver’s main function 
is the barrier-cleansing, it can also serve as a 
powerful filter, remove and destroy bacteria 
and neutralizing toxins which are produced by 
metabolic reactions. The liver could be 
adversely affected in cases of poisoning, drug 
overdose and poor nutrition. However, it 
rarely makes itself felt at the beginning of the 
disease because of its high functional reserve. 
Often times, when the symptoms manifest, it 
is obvious that the damage has been done 
and extensive. Among other functions of the 
liver is the production of a large amount of 
enzymes which when hepatocytes are 
destroyed they leak directly into the blood 
and serve as useful indicator of the degree of 
liver damage (Burtiset al., 2006). Therefore, 
liver cannot be overlooked in the use of 
thiocyanate as an anti-sickling drug. 
MATERIALS AND METHODS 
Ethics concerning experimental animals 
The experimental protocol was approved by 
the University Ethical Review committee, 
University of Ilorin, Ilorin, Nigeria. The 
research was approved to be in compliance 
with the Institutional Animal Care and Use 
Committee (IACUC). 
Experimental animals 
Twenty (20) adult male Wistar rats with an 
average weight of 230.5g were obtained from 
the Faculty of Veterinary Medicine of the 
University of Ilorin and acclimatized in the 
animal house of the College of Health 
Sciences in the same university for two 
weeks. The animals were kept at normal room 
temperature. Pelletized rats feeds and water 
were made availablead libitum. The animals 
were grouped randomly into four, each 
comprising of five animals. Group A served as 
control while groups B, C, and D were given 
10mg/Kg/day (therapeutic dose, TD), 
20mg/Kg/day and 30mg/Kg/day (both test 
lethal dose) thiocyanate (SCN) respectively. 
Just before the start of administration, all the 
animals were weighed and records kept. The 
weighing was continued weekly throughout 
the period of the treatment. 
Preparation of Thiocyanate solution 
 The Potassium thiocyanate (KSCN) 
administered is a product of Labtech 
chemicals and was bought from 
Labtrade(Nig.) Company, Ilorin, Nigeria. The 
salt pellet was measured carefully using 
sensitive weight scale with respect to the 
weight of the animals and dose specified for 
each test group. Thereafter, it was dissolved 
in distilled water and shaken vigorously to 
obtain a homogenous solution. 
Group A (Control): Distilled water 
Group B          : 10mg/Kg/day           
(Oyewole and Malomo, 2009) 
Group C          : 20mg/Kg/day 
Group D          : 30mg/Kg/day 
Drug administration 
Distilled water - The control group (A) was 
given 1.0ml of distilled water daily alongside 
the treated group; 
Thiocyanate solution- The treated groups (B, 
C, & D) was given 1.0ml/day of the 
thiocyanate solution. 
The thiocyanate solution was given through 
the oral cavity using an oral cannula daily for 
a period of twenty-eight (28) days (Oyewoleet 
al., 2009). 
	






On completion of the 28 days treatment 
period, all the experimental animals were 
sacrificed via cervical dislocation. The animals 
were pinned to a dissecting board after which 
an incision through the lineaalba and sternum 
was made to expose the thoraco-abdominal 
region. Part of the liver was cut for 
homogenate sample and the rest were 
properly fixed with 4% paraformaldehyde by 
the perfusion method. 
Blood collection 
Blood samples were drawn from the apex of 
the heart of the rats in every group using a 
5ml syringe. The blood samples were then 
emptied into plain specimen bottles for 
onward biochemical assay of total bilirubin. 
This was done before the perfusion fixation. 
Homogenate preparation 
The liver samples obtained from each animal 
before fixation were weighed, dropped into 
separate plain sample bottles containing 
corresponding volume of ice cold 0.25M 
sucrose solution. Each of the sample was 
homogenized using mortar and pestle. The 
resulting homogenates were examined for the 
biochemical assay of alanine aminotransferase 
(ALT) and aspartate aminotransferase (AST). 
Histological and staining procedures 
The liver tissues were properly fixed in 4% 
paraformaldehyde and processed duly. They 
were stained with haematoxylin and eosin 
(H&E) and periodic acid-Schiff (PAS) after 
which observations were made with a light 
Olympus microscope at a magnification of 
×400. 
Biochemical assay 
Common and specific hepatocellular marker 
were analysed from the tissue homogenate 
prepared. Alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST) was 
determined by the modified method of 
Reitman and Frankel which is based on the 
amount of pyruvate and oxaloacetate 
hydrazine produced in each case (Reitman 
and Frankel, 1957). 
 
Similarly, the serum total bilirubin was 
determined as done routinely by the 
description of Burtis and Ashwood (Balisteri 
and Rej, 1994). 
Statistical analysis 
 The animal weights and biochemistry 
data were analysed for mean, standard error 
of mean and significant difference by ANOVA 
using the SPSS version 22.0 for windows. 





All the animals showed no spontaneous 
adverse reaction to the different doses of SCN 
treatment. The animals were closely 
monitored over the first 24-hours post 
administration and subsequently throughout 
the course of treatment. Over the time, the 
animals were generally calm and relaxed with 
no obvious “agitations, hyperreflexia, tinnitus, 
miosis” lesion, discoloration or deformities 
noticed. Varying weight changes were also 
detected among the groups. For group A 
(control) there was a 15.4g gain in weight 
before sacrifice was made. The weight change 
in group B (10mg/Kg/day) was non-uniform 
though a little gain was finally observed. The 
weight changes in the test groups C 
(20mg/Kg/day), and D (30mg/Kg/day) were 
relatively progressive. Generally the changes 
in weight measured before and after SCN 
administration were not statistically significant 
across all the four experimental groups. This 










Table 1: Comparison of weight of rats before and after the administration  
Weight differences in the experimental animal groups 
 Final weight (g) Initial weight (g) Differences (g) 
A (control) 








































Figure 1: Bar chart showing the mean weight of experimental animals before and after administration. 
 
Histological analysis 
Experimental rats treated with 10mg/Kg/day 
SCN exhibited mild cellular hyperplasia, 
vascular congestion, and prominent sinusoids. 
Severe cellular hyperplasia with lysed red 
blood cell (RBC) filled central vein and 
disruption of sinusoidal pathway appear in the 
rats given 20mg/Kg/day SCN. The group 
which received 30mg/Kg/day displayed multi-
foci cellular and fatty degeneration. Their 
hepatocytes were also compressed with 
ballooning sinusoid. But rats given distilled 
water showed normal hepatocytes with 
neither cell damage nor death in slide sections 
as shown below: 
  
GROUPS	






Figure 2: Liver (H&E×400): Histology of the rat liver that was given 1ml distilled water, 10mg/Kg/day, 20mg/Kg/day & 
30mg/Kg/day SCN respectively. (A) Given 1ml distilled water/day for 28 days, shows normal central vein (CV), hepatocyte 
(H) and sinusoid(S). (B) Given 10mg/Kg/day SCN for 28 days, shows mild cellular hyperplasia and vascular congestion 
due to lysed red blood cells (RBCs). (C) Given 20mg/Kg/day SCN for 28 days, shows severe cellular hyperplasia and 
disintegration. The central vein also contains lysed RBC. (D) Given 30mg/Kg/day SCN for 28 days, show multi-foci cellular 
and fatty degeneration with its hepatocytes(H) compressed by ballooning sinusoids. 
 
Biochemical assay 
The analysis of biochemical enzymes 
(ALT&AST) in tissue homogenate showed a 
relative increase though not absolutely 
consistent. Quantitatively determined serum 
total bilirubin also increased progressively 
from the control to group D which received 
30mg/Kg/day for the twenty eight day period. 
The elevation in the levels of AST and total 
bilirubin was not significant among the 
treated groups. However the increase 
observed in ALT levels was significant in 
groups C & D but not in group B when 
compared with the control. This is illustrated 













Figure 3: Liver (PAS×400): Histology of the rat liver that was given 1ml distilled water, 10mg/Kg/day, 20mg/Kg/day & 
30mg/Kg/day SCN respectively. (A) Given 1ml distilled water/day for 28 days, shows normal hepatocytes(H), central 
vein(CV) and sinusoids(S); PAS positive substance(PPS) stained magenta observed. (B) Given 10mg/Kg/day SCN for 28 
days, shows normal hepatocytes(H), central vein(CV) with well-defined wall and sinusoid(S) but mild cytoplasmic 
distortion; PPS abundant in the cytoplasm. (C) Given 20mg/Kg/day SCN for 28 days, shows moderate cellular hyperplasia 
and fatty degeneration; PPS also abundant though mildly distorted. (D) Given 30mg/Kg/day SCN for 28 days, shows 




















Table 2: Results of tissue alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
and serum total bilirubin activities. 


















Values are mean± SEM of five animals. 





























Figure 4: Bar chart showing the result of alanine aminotransferase (ALT) activities in the liver. *Significant difference 
(P<0.05) exist between ALT levels of animals in groups C&D compared to A&B. 
SCN-THIOCYANATE 
GROUPS	
























































Figure 6: Bar chart showing the result of total bilirubin activities in the serum. 
DISCUSSION 
From observations made, the experimental 
animals maintained a constant rate of food 
and water intake from the beginning to the 
end of the experiment. This resulted in to a 
subtle weight increase that is not significant 
when a comparison of the initial and final 
weights was made. The increased weight can 
be attributed to normal growth and 
development of the rats as well as lack of 










liver is often vulnerable to the effects of 
xenobiotic-induced injury due to its vital role 
in the metabolism of foreign compounds and 
portal location within the circulatory system 
(Babalola et al., 2001).  
 
The histological tissue sections stained with H 
& E had a normal appearance of the sinusoids 
and hepatocytes radiating from the central 
vein in the control group. However an 
observation of those in groups B, C, and D 
had appearances varying from mild cellular 
hyperplasia, severe cellular hyperplasia and 
prominence of sinusoid to multi-foci cellular 
and fatty degeneration as well as ballooning 
sinusoid. As for the sections stained with 
periodic acid-Schiff (PAS), hepatocytes of 
control group shows normal histoarchitecture 
and magenta coloured PAS positive substance 
(PPS)-glycogen. Glycogen granules revealed 
by the periodic acid-Schiff was observed in 
abundance across the treated groups B and C 
except in group D where it was only sparse. A 
progressive disruption of hepatocyte 
histoarchitecture was also noticed with mild 
cytoplasmic distortion in group B; moderate 
cellular hyperplasia and fatty degeneration in 
group C; and severe cell death, fatty 
degeneration, and ballooning sinusoids in 
group D, indicating hepatocellular damaging 
effects of SCN in dose dependent order in 
male wistar rats. This study suggests that 
mild to severe hepatocyte hyperplasia, multi-
foci cellular and fatty degeneration are 
prominent responses to SCN administration 
with increasing dose. The predominant or 
persistent hyperplastic response should 
therefore be considered to be an adverse 
effect.  
 
Nevertheless, hepatic injury is usually related 
with alterations in the concentration of serum 
total bilirubin and tissue levels of some 
enzymes i.e. ALT, AST (Whitby et al., 1984). 
Bilirubin is formed by the catabolism 
(breakdown) of haemoglobin in the liver, 
spleen and bone marrow (Vasudevan and 
Sreekumari, 2007). Bilirubin measurement is a 
useful index of determining the excretory 
function of the liver and assessment of 
haemolytic anaemia. An increase in tissue or 
serum bilirubin concentration results in 
jaundice and it occurs in toxic or infectious 
disease of the liver e.g. hepatitis or bile 
obstruction (Edem and Usoh, 2009).These 
results showed an increase in tissue ALT level 
of group B that was not significant relative to 
the value in the control group. However 
significant elevation of ALT levels in groups C 
and D was observed compared to the control. 
The increased levels of liver enzymes are an 
indicator of disturbance of hepatocytes 
membranes (Rezaei-Moghadamet al., 2012). 
Thus the observed significant (p<0.05) 
increase is a pointer of hepatocellular damage 
arising from the use of SCN at doses higher 
than the therapeutic. This finding conform 
with the result obtained by Bolaji and Olabode 
(2011) where a significant increase in liver 
enzymes (ALT & AST) was observed following 
the administration of 3mg/Kg of cyanide to 
rats for 15 days. Similarly a significant 
increase in the concentration of ALT and AST 
that relates to the necrosis of hepatocytes 
was reported from the administration of 
10mg/Kg SCN daily for twenty-eight (28) days 
(Oyewole and Malomo, 2009).Analysis also 
show that serum total bilirubin concentration 
increased in all the treated groups, though 
not significantly. The increase in total bilirubin 
can be explained by the thiocyanate induced 
inhibition of transporters mediating bilirubin 
uptake into hepatocytes (OATP1B1) or release 
of conjugated bilirubin from hepatocytes into 
bile (MRP2). This may cause 
hyperbilirubinaemia which eventually leads to 
jaundice. The analysis of AST showed 
insignificant increase in some treated groups 
(groups B and D) and decrease in group B 
when compared to the control. The 
corresponding histological and biochemical 
enzymes results of this study can be used to 
infer that SCN use in sickle cell disease 
management regimen can cause 
hepatocellular damage in wistar rats. 
 





In conclusion, administering SCN in sickle cell 
disease management regimen can affect the 
cellular make-up of the liver at the therapeutic 
dose. A similar potentially toxic effect resulted 
from doses higher than the therapeutic. So an 
uninterrupted use of SCN at the therapeutic 
dose must be avoided and not considered at 
all for doses beyond the therapeutic. 
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